US: S&P 500 eases after vaccine news rally
[NEW YORK] The S&P 500 dipped at the open on Tuesday as excitement over signs of a first successful late-stage Covid-19 vaccine trial faded, while investors continued to pull money out of the big tech companies that have benefited most from the pandemic.
The Dow Jones Industrial Average rose 96.20 points, or 0.33 per cent, at the open to 29,254.17.
The S&P 500 opened lower by 7.24 points, or 0.20 per cent, at 3,543.26, while the Nasdaq Composite dropped 91.34 points, or 0.78 per cent, to 11,622.44 at the opening bell.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Capital Markets & Currencies
Stocks to watch: CLI, Great Eastern, MIT, Sheng Siong, iFast, OUE, Far East Orchard
Europe: Stocks retreat on earnings gloom, weak US economic data
US: Stocks hit by GDP data, Meta results
Singapore stocks end lower after US market wobbles ahead of CPI data; STI down 0.2%
LSEG reports in-line first quarter as Microsoft partnership progresses
Japan brokerage Daiwa’s Q4 profit more than doubles as markets recover